Chesley Taft & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.17M | Sell |
55,810
-3,023
| -5% | -$354K | 0.28% | 77 |
|
|
2026
Q1 | $7.08M | Sell |
58,833
-1,652
| -3% | -$191K | 0.3% | 76 |
|
|
2025
Q4 | $6.37M | Buy |
60,485
+5,213
| +9% | +$489K | 0.25% | 83 |
|
|
2025
Q3 | $4.64M | Sell |
55,272
-3,126
| -5% | -$257K | 0.2% | 96 |
|
|
2025
Q2 | $4.62M | Sell |
58,398
-2,490
| -4% | -$198K | 0.21% | 93 |
|
|
2025
Q1 | $5.47M | Buy |
60,888
+35
| +0.1% | +$3.27K | 0.26% | 84 |
|
|
2024
Q4 | $6.05M | Sell |
60,853
-4,994
| -8% | -$515K | 0.28% | 73 |
|
|
2024
Q3 | $7.48M | Sell |
65,847
-190
| -0.3% | -$22.6K | 0.36% | 65 |
|
|
2024
Q2 | $8.18M | Buy |
66,037
+5,215
| +9% | +$672K | 0.41% | 61 |
|
|
2024
Q1 | $8.03M | Buy |
60,822
+6,235
| +11% | +$769K | 0.41% | 61 |
|
|
2023
Q4 | $5.95M | Sell |
54,587
-972
| -2% | -$101K | 0.33% | 68 |
|
|
2023
Q3 | $5.72M | Sell |
55,559
-330
| -0.6% | -$35.6K | 0.37% | 68 |
|
|
2023
Q2 | $6.45M | Sell |
55,889
-615
| -1% | -$69.8K | 0.4% | 64 |
|
|
2023
Q1 | $6.01M | Buy |
56,504
+204
| +0.4% | +$22K | 0.39% | 68 |
|
|
2022
Q4 | $6.25M | Buy |
56,300
+770
| +1% | +$78.7K | 0.43% | 62 |
|
|
2022
Q3 | $4.78M | Sell |
55,530
-213
| -0.4% | -$19K | 0.35% | 72 |
|
|
2022
Q2 | $5.08M | Buy |
55,743
+143
| +0.3% | +$12.7K | 0.35% | 73 |
|
|
2022
Q1 | $4.76M | Sell |
55,600
-6,230
| -10% | -$491K | 0.28% | 80 |
|
|
2021
Q4 | $4.74M | Buy |
61,830
+4,320
| +8% | +$344K | 0.25% | 89 |
|
|
2021
Q3 | $4.32M | Buy |
57,510
+250
| +0.4% | +$19K | 0.25% | 91 |
|
|
2021
Q2 | $4.45M | Sell |
57,260
-3,068
| -5% | -$228K | 0.26% | 87 |
|
|
2021
Q1 | $4.43M | Buy |
60,328
+471
| +0.8% | +$34.7K | 0.26% | 86 |
|
|
2020
Q4 | $4.67M | Sell |
59,857
-471
| -0.8% | -$36K | 0.3% | 78 |
|
|
2020
Q3 | $4.78M | Sell |
60,328
-6,926
| -10% | -$542K | 0.34% | 69 |
|
|
2020
Q2 | $4.96M | Sell |
67,254
-22,189
| -25% | -$1.67M | 0.38% | 67 |
|
|
2020
Q1 | $6.57M | Sell |
89,443
-1,271
| -1% | -$99.9K | 0.6% | 49 |
|
|
2019
Q4 | $7.87M | Buy |
90,714
+2,872
| +3% | +$236K | 0.57% | 54 |
|
|
2019
Q3 | $7.06M | Sell |
87,842
-116,724
| -57% | -$9.35M | 0.55% | 55 |
|
|
2019
Q2 | $16.4M | Buy |
204,566
+969
| +0.5% | +$74.2K | 1.28% | 24 |
|
|
2019
Q1 | $16.2M | Buy |
203,597
+17,067
| +9% | +$1.28M | 1.35% | 22 |
|
|
2018
Q4 | $13.6M | Sell |
186,530
-944
| -0.5% | -$66.6K | 1.31% | 21 |
|
|
2018
Q3 | $12.7M | Buy |
187,474
+289
| +0.2% | +$18.4K | 1.01% | 36 |
|
|
2018
Q2 | $10.8M | Buy |
187,185
+104,180
| +126% | +$5.88M | 0.93% | 35 |
|
|
2018
Q1 | $4.31M | Sell |
83,005
-1,942
| -2% | -$105K | 0.38% | 72 |
|
|
2017
Q4 | $4.56M | Sell |
84,947
-84,202
| -50% | -$4.67M | 0.39% | 75 |
|
|
2017
Q3 | $10.3M | Buy |
169,149
+104,704
| +162% | +$6.35M | 0.89% | 36 |
|
|
2017
Q2 | $3.94M | Sell |
64,445
-1,203
| -2% | -$73.2K | 0.36% | 80 |
|
|
2017
Q1 | $3.98M | Sell |
65,648
-1,364
| -2% | -$82.8K | 0.37% | 75 |
|
|
2016
Q4 | $3.76M | Buy |
67,012
+655
| +1% | +$38.3K | 0.37% | 76 |
|
|
2016
Q3 | $3.95M | Sell |
66,357
-4,666
| -7% | -$273K | 0.4% | 73 |
|
|
2016
Q2 | $3.9M | Buy |
71,023
+105
| +0.1% | +$5.59K | 0.4% | 73 |
|
|
2016
Q1 | $3.58M | Sell |
70,918
-88
| -0.1% | -$4.31K | 0.38% | 77 |
|
|
2015
Q4 | $3.58M | Sell |
71,006
-8,956
| -11% | -$452K | 0.38% | 78 |
|
|
2015
Q3 | $3.77M | Buy |
79,962
+183
| +0.2% | +$9.72K | 0.41% | 72 |
|
|
2015
Q2 | $4.33M | Buy |
79,779
+367
| +0.5% | +$20.6K | 0.44% | 70 |
|
|
2015
Q1 | $4.36M | Buy |
79,412
+3,175
| +4% | +$180K | 0.45% | 71 |
|
|
2014
Q4 | $4.13M | Buy |
76,237
+309
| +0.4% | +$17.2K | 0.42% | 73 |
|
|
2014
Q3 | $4.29M | Buy |
75,928
+167
| +0.2% | +$9.38K | 0.45% | 72 |
|
|
2014
Q2 | $4.18M | Buy |
75,761
+3,740
| +5% | +$204K | 0.43% | 75 |
|
|
2014
Q1 | $3.9M | Buy |
72,021
+682
| +1% | +$35.3K | 0.42% | 75 |
|
|
2013
Q4 | $3.41M | Sell |
71,339
-17,547
| -20% | -$802K | 0.34% | 82 |
|
|
2013
Q3 | $4.04M | Buy |
88,886
+3,518
| +4% | +$161K | 0.44% | 75 |
|
|
2013
Q2 | $3.78M | Buy |
+85,368
| New | +$3.81M | 0.44% | 74 |
|
Other funds holding MRK
LMFP
ATO
AAMU
Chesley Taft & Associates's MRK Position: Q2 2026 in Review
Chesley Taft & Associates reduced its Merck (MRK) stake by 5.1% in Q2 2026, selling an estimated $354K and leaving 55,810 shares worth $7.17M. The position accounts for 0.28% of the portfolio, ranked #77.
Chesley Taft & Associates first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.4M in Q2 2019. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Chesley Taft & Associates held 55,810 shares of Merck worth $7.17M as of Q2 2026.
- Chesley Taft & Associates sold 3,023 Merck shares in Q2 2026, an estimated $354K.
- Merck made up 0.28% of Chesley Taft & Associates's portfolio in Q2 2026, its #77 holding.
- Chesley Taft & Associates first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Chesley Taft & Associates's Merck position peaked at $16.4M in Q2 2019.
- 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.